Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLDB compared with BCAX: revenue, margins and what each company keeps, and the suppliers and customers both name
SLDB
Solid Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLDB
Solid Biosciences Inc.
vs
BCAX
Bicara Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SLDB
Solid Biosciences Inc.
Change
6.20
▼
−2.97%
· post 6.20
Mkt cap
$664.8M
BCAX
Bicara Therapeutics Inc.
Change
9.11
▼
−6.38%
· post 8.91
Closed
Oct 30 '26
Mkt cap
$620.2M
vs
Compare
Closed
Oct 30 '26
SLDB
Solid Biosciences Inc.
vs
BCAX
Bicara Therapeutics Inc.
6.20
▼
−2.97%
post 6.20
Price
9.11
▼
−6.38%
post 8.91
$664.8M
Mkt cap
$620.2M
Change
Change
SLDB
6.20
▼
−2.97%
vs
BCAX
9.11
▼
−6.38%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SLDB, solid
BCAX, dashed
Supply-chain overlap
Revenue flow
SLDB: latest quarter not drawable. BCAX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SLDB
7
—
FA212
unlisted
supplier
—
ICS Maugeri
unlisted
supplier
—
University of Pennsylvania
unlisted
supplier
—
University of Washington
unlisted
supplier
3 more · SLDB chain
›
Shared
0
No shared counterparties.
Only BCAX
2
MSD
MSD International GmbH and MSD International Business GmbH
supplier
—
Biocon
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR